págs. 603-605
Katharine Barnes
pág. 605
Novel prenyltransferase enzymes as a tool for flavonoid prenylation
Giuliano Delle Monache, Pilar Menendez, Bruno Botta, Alberto Boffi
págs. 606-608
A therapeutic role for cannabinoid CB<sub>1</sub> receptor antagonists in major depressive disorders
Eleni T. Tzavara, George G. Nomikos, Richard J. Davis, Jeffrey M. Witkin, Xia Li
págs. 609-617
Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors
Tommaso Costa, Susanna Cotecchia
págs. 618-624
William P. Clarke, Kelly A. Berg, Umberto Spampinato, John A. Harvey
págs. 625-630
Antidepressant action: to the nucleus and beyond
Jessica E. Malberg, Julie A. Blendy
págs. 631-638
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
Julien Hanson, Domenico Pratico, Jean-Michel Dogné
págs. 639-644
Activity-driven postsynaptic translocation of CaMKII
Johannes W. Hell, Michelle A. Merrill, Yucui Chen, Stefan Strack
págs. 645-653
An emerging role for PtdIns(4,5)P <sub>2</sub>-mediated signalling in human disease
Nullin Divecha, Kees Jalink, Jonathan R. Halstead
págs. 654-660
© 2001-2025 Fundación Dialnet · Todos los derechos reservados